Moderna (MRNA) Surges Nearly 8% as Q1 Revenue Crushes Wall Street Forecasts

Moderna (MRNA) shares surge 8% after Q1 revenue hits $389M, tripling year-over-year and beating estimates on strong international vaccine sales.

The post Moderna (MRNA) Surges Nearly 8% as Q1 Revenue Crushes Wall Street Forecasts appeared first on Blockonomi.